Get the Stockscreener App
3.11
1.63%
0.05
After Hours:
2.97
-0.14
-4.50%
Psyence Biomedical Ltd stock is traded at $3.11, with a volume of 20,263.
It is up +1.63% in the last 24 hours and down -11.40% over the past month.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
See More
Previous Close:
$3.06
Open:
$3.02
24h Volume:
20,263
Relative Volume:
0.01
Market Cap:
$11.86M
Revenue:
-
Net Income/Loss:
$1.52M
P/E Ratio:
-0.492
EPS:
-6.3213
Net Cash Flow:
$-1.14M
1W Performance:
+1.63%
1M Performance:
-11.40%
6M Performance:
-37.02%
1Y Performance:
-89.85%
1-Day Range:
$2.93
$3.2099
1-Week Range:
$2.93
$3.275
52-Week Range:
$0.6254
$74.94
Psyence Biomedical Ltd Stock (PBM) Company Profile
Compare PBM vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
3.11 | 11.67M | 0 | 1.52M | -1.14M | -6.3213 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Psyence Biomedical Ltd Stock (PBM) Latest News
PBMPsyence Biomedical Ltd Earnings - Finviz
Tranche Update on Psyence Biomedical Ltd.'s Equity Buyback Plan announced on January 12, 2026. - marketscreener.com
PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine - Stocktwits
Psyence Biomedical Ltd (PBM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
$Psyence Biomedical (PBM.US)$ - Moomoo
Psyence Biomedical (Nasdaq: PBM) outlines losses, cash runway and trial risks in 20-F - Stock Titan
Psyence Biomedical Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Nasdaq, S&P 500 Futures Fall, Oil Risk Back In Focus After Trump’s Iran Escalation: Why PBM, FRMI, ASTS, BATL Are Keeping Traders Engaged Today - Stocktwits
Psyence Biomedical Ltd (PBM) Valuation: PE, PB & Fair Value Analysis - TradingKey
PBMWW | Psyence Biomedical Ltd. Warrant Insider Trading - Quiver Quantitative
Psyence Biomedical Ltd (PBM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Psyence Biomedical Ltd (PBM) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Ltd (PBM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Psyence Biomedical Ltd (PBMWW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBMWW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Psyence Biomedical Ltd (PBMWW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Psyence Biomedical Ltd (PBM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Psyence Biomedical Ltd (PBMWW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Ltd (PBM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Psyence Biomedical Ltd (PBMWW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Psyence Biomedical Ltd (PBMWW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Psyence Biomedical Ltd (PBMWW) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBMWW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Psyence Biomedical Ltd (PBMWW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PBM News | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
PBMWW Warrants Slide 9.25% as Psyence Biomedical Faces Continued Selling PressureGamma Exposure - newsline.com
Jeffrey Weiner holds 59,750 shares in PSYENCE BIOMEDICAL LTD. (PBM) - Stock Titan
Psyence Biomedical Company Profile & Introduction - Moomoo
Psyence Biomedical Corrects Technical Error in 2023 Equity Incentive Plan - TipRanks
Psyence Biomedical (PBM) corrects error in 2023 equity incentive plan - Stock Titan
Psyence Biomedical draws attention premarket after filing on 30% stake - Bez Kabli
Psyence Biomedical (PBM) Surges Over 7%: Bullish Momentum Builds Near ResistanceEnding Diagonal - newsline.com
Psyence Labs Discloses Investment in PSYENCE BIOMEDICAL LTD. with 30.05% Stake - TradingView
Psyence Labs gains 30.05% ownership of Psyence Biomedical (PBM) - Stock Titan
Psyence Biomedical Ltd. Warrant (PBMWW) Slides 8.94% as Stock Hovers at $0.03Market Cap Weight - The Legal Advocate
Psyence Biomedical (PBM) Rallies 5.85% as Shares Test Key Resistance Near $4.56Value Area High - The Legal Advocate
Psyence Biomedical Ltd. (PBM) Edges Higher Amid Sector Rotation and Key Technical LevelsUpthrust Pattern - The Legal Advocate
Psyence Biomedical Warrants (PBMWW) Edge Higher; Support and Resistance Converge at $0.03Momentum Breakout Ideas - The Legal Advocate
$Psyence Biomedical (PBM.US)$ picked me up lets goooo - Moomoo
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing - marketscreener.com
Psyence BioMed Announces U.S. Strategic Engagement - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
PBM Stock Chart | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
TradingKey - TradingKey
Psyence Biomedical Ltd Stock (PBM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.17%
2.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):